diabetestalk.net

Finnish Researchers Set To Start Type 1 Diabetes Vaccine Trials?

Finnish Researchers Set to Start Type 1 Diabetes Vaccine Trials?

Finnish Researchers Set to Start Type 1 Diabetes Vaccine Trials?

In July 2017, it was announced that Finnish researchers would begin human trials of a Type 1 diabetes vaccine in 2018.
On 19 July 2017, the Finnish news web site Yle reported that a group of Finnish researchers had developed a vaccine for Type 1 diabetes, and that human trials were set to begin in 2018:
A vaccine for type 1 diabetes developed by Finnish researchers will be tested on mainly Finnish human subjects in late 2018, researchers announced on Tuesday. The scientists first found that the prototype works effectively and safely on mice, and now say that the vaccine could be in mainstream use within eight years if the coming rounds of tests prove successful.
One skeptical reader asked us to check out the story.
Yle is Finland’s public broadcasting corporation (akin to NPR or the BBC). T he names of the lead researchers and their universities are real, the announcement of vaccine trials is real, and the story is true.
On 18 July 2017, the University of Tampere in Finland announced that Professor of Virology Heikki Hyöty and his team of researchers had identified a particular strand of enteroviruses (viruses transmitted through the intestines) linked to Type 1 diabetes, and developed a vaccine against them.
“Already now it is known that the vaccine is effective and safe on mice,” Hyöty said. “The developing process has now taken a significant leap forward as the next phase is to study the vaccine in humans.”
The university’s statement continued:
In the first clinical phase, the vaccine will be studied in a small group of adults to ensure the safety of the va Continue reading

Rate this article
Total 1 ratings
With diabetes rising at alarming rate, California puts money behind prevention campaign

With diabetes rising at alarming rate, California puts money behind prevention campaign

California officials decided this week to dedicate $5 million to prevent people at high risk for diabetes from getting the disease, hoping to stem the huge numbers of Californians expected to be diagnosed in the coming years.
Currently 9% of Californians have diabetes, but a study last year found that 46% of adults in California have prediabetes, a condition in which blood glucose levels are higher than normal but not high enough to be considered diabetic.
“That is a staggering number,” said Flojaune G. Cofer, research and state policy director for Davis-based Public Health Advocates, which sponsored the bill, SB 97, that adds the new funding.
Cofer said that if nothing is done to stop prediabetics from developing diabetes, millions more Californians will become diabetic in the next five years and the state’s diabetes rate will likely double. Approximately 70% of prediabetics will become diabetic in their lifetime.
Gov. Jerry Brown on Monday approved $5 million to pay for Medi-Cal recipients to enroll in the Diabetes Prevention Program starting July next year. Participants must be overweight and have high blood sugar levels, but not yet be considered diabetic.
The program helps people lose 5% to 7% of their body weight by eating more healthfully, exercising more and reducing stress — and has been shown to cut the risk of developing diabetes by more than half. California will become the third state to cover the program as a Medicaid benefit after Montana and Minnesota.
Daniel Zingale, senior vice president at the California Endowment, said Medi-Cal has long covered t Continue reading

Avoiding Eye Complications

Avoiding Eye Complications

When it comes to diabetes-related eye complications, the good news is that most cases of severe vision loss due to diabetes are preventable. The bad news is that tens of thousands of people still lose vision to diabetes each year, despite all that is known about prevention and treatment.
Diabetes is the leading cause of new blindness for American adults between the ages of 20 and 74. The American Diabetes Association (ADA) estimates that 12,000–24,000 people in the United States lose their vision to diabetic retinopathy each year, and studies have shown that people with diabetes have a fivefold to twenty-fivefold increased risk of blindness in their lifetimes.
-- Keep an eye on your vision! Learn about preventive steps and treatments for diabetic retinopathy from retinal specialist Dr. Charles Wykoff. >>
However, these numbers very likely underestimate the true incidence of vision loss and blindness, because diabetes can cause a variety of eye diseases other than retinopathy, several of which can cause severe visual impairment (see “Eye Diseases Associated With Diabetes” ). Moreover, these statistics ignore vision loss less severe than “legal blindness” (defined as vision on the eye chart worse than 20/200 with the use of prescription lenses or severe loss of peripheral vision to within 20 degrees of central vision). But even less severe vision loss can and does substantially affect quality of life for thousands of people with diabetes.
Prevention strategies
Why do so many people continue to lose their sight to diabetes when so much is known about preventing and t Continue reading

Can people with diabetes eat peanut butter?

Can people with diabetes eat peanut butter?

Peanut butter may help people to manage diabetes, a condition that affects blood sugar levels. How exactly does this popular snack help to control the condition?
A diet high in magnesium is thought to offer protective benefits against the development of diabetes. Peanuts are a good source of magnesium.
Natural peanut butter and peanuts are also low glycemic index (GI) foods. This means that they have a lower effect on blood sugar levels.
This article explores research into the impact of peanut butter on diabetes, to help people with diabetes decide whether eating it could improve their condition. It also considers any risks involved and looks at other healthful snacks for people with diabetes.
How GI affects blood sugar
GI is a 100-point scale applied to foods. This scale measures how blood sugar and insulin spike after eating specific food types.
Foods that are digested slowly and release sugar gradually into the blood stream have a lower GI. Peanuts have a GI score of just 14, making them one of the lowest GI foods.
Foods high in GI cause blood sugar and insulin to spike severely after eating them. This is followed by a crash in blood sugar that can result in hunger, cravings, and tiredness.
These cycles of spiking and crashing blood sugar and insulin levels are not good for the body. They can contribute to the development of type 2 diabetes.
Research into peanut butter and blood sugar
By contrast, low-GI foods can help people to better control their blood sugar levels.
For example, a 2012 study looked into eating peanut butter or peanuts at breakfast. This helped obese w Continue reading

Watching TV three hours a day linked to type 2 diabetes in children

Watching TV three hours a day linked to type 2 diabetes in children

INDYPULSE
Watching TV three hours a day linked to type 2 diabetes in children
Children who spend more than three hours a day in front of the TV or a computer may be at greater risk of developing type 2 diabetes.
Increased levels of body fat and insulin resistance in children were linked to regular extended periods of screen time in a new study published in the journal Archives of Disease in Childhood.
Diabetes risk factors including blood fat and glucose levels, blood pressure and resistance to insulin were measured in 4,495 children aged nine and ten from primary schools in London, Birmingham and Leicester.
Children who said they spent the most time watching TV or using electronic devices each day were found to be more likely to exhibit physical risk factors for diabetes.
“Our findings suggest that reducing screen time may be beneficial in reducing type 2 diabetes risk factors, in both boys and girls and in different ethnic groups from an early age,” wrote the researchers from St George’s, University of London.
The scientists said their findings were of “considerable potential public health interest” but emphasised further research was needed to prove the link between diabetes risk and screen time.
“This is particularly relevant, given rising levels of type 2 diabetes, the early emergence of type 2 diabetes risk, and recent trends suggesting that screen time related activities are increasing in childhood and may pattern screen-related behaviours in later life,” they said.
Previous research has suggested a link between time spent on screens and heightened type Continue reading

No more pages to load

Popular Articles

  • Researchers identify key mechanism by which obesity causes type 2 diabetes

    UT Southwestern researchers have identified a major mechanism by which obesity causes type 2 diabetes, which is a common complication of being overweight that afflicts more than 30 million Americans and over 400 million people worldwide. Researchers found that in obesity, insulin released into the blood by the pancreas is unable to pass through the cells that form the inner lining of blood vessels ...

  • Researchers link Alzheimer’s gene to Type 3 diabetes

    Researchers have known for several years that being overweight and having Type 2 diabetes can increase the risk of developing Alzheimer’s disease. But they’re now beginning to talk about another form of diabetes: Type 3 diabetes. This form of diabetes is associated with Alzheimer's disease. Type 3 diabetes occurs when neurons in the brain become unable to respond to insulin, which is essential ...

  • New insulin pill developed by American researchers that could treat type 1 diabetes

    American researchers have developed an insulin pill that could provide a less painful way for people with type 1 diabetes to control their blood sugar levels. This new technology is known as a Cholestosome, which was reported on this week at the 252nd National Meeting and Exposition of the American Chemical Society (ACS). Mary McCourt, a researcher from Niagara University, explains that a Cholesto ...

  • Researchers identify gene variants linked to both type 2 diabetes and CHD risk

    Type 2 diabetes (T2D) has become a global epidemic affecting more than 380 million people worldwide; yet there are knowledge gaps in understanding the etiology of type-2 diabetes. T2D is also a significant risk factor for coronary heart disease (CHD), but the biological pathways that explain the connection have remained somewhat murky. Now, in a large analysis of genetic data, published on August ...

  • Researchers Make Progress on a Pill to Stop Type 2 Diabetes

    Pharmaceutical researchers are one step closer to making a pill that can reverse the symptoms of type 2 diabetes. They published their research in the journal Nature Chemical Biology. Diabetes and its complications are a major issue within the United States and abroad. In 2012, the American Diabetes Association reported that 29.1 million Americans, or 9.3 percent of the population, lived with diab ...

  • Type 2 diabetes has its breakthrough – researchers take note

    There’s not a week that goes by without a team of researchers thinking they’ve found a new way to treat type 2 diabetes. “This drug could represent a new avenue for treating type 2 diabetes.” Each time I see a line like this I can’t help but shake my head a little. Why? Because I know full well that the breakthrough towards treating type 2 diabetes has already been found. A few years ago ...

  • Clinical Trials and the Type 1 Diabetes Cure

    WRITTEN BY: Stephen Gitelman, MD I am often asked the question, “Where is the cure for Type 1 diabetes (T1D)?” For those with long-standing diabetes, we are very close to replicating insulin producing beta cell functionality or the actual replacement of those cells — either with closed loop systems with continuous glucose sensor driving an insulin pump, or use of replacement beta cells deriv ...

  • 4 Promising New and Upcoming Clinical Trials for Type 1 Diabetes

    Type 1 Diabetes is a disease where your own immune system mistakenly attack your “pancreatic islets”- small clusters of cells in the pancreas that contain insulin-producing “beta” cells. There is currently no cure for Type 1 Diabetes, although it can be managed. Type 1 diabetics must carefully time when and what they eat, monitor their blood glucose by pricking their fingers, and routinely ...

  • Update: Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure

    Update (15/11/2017): Imcyse has officially started recruiting patients to test its therapy for type 1 diabetes. The clinical trial will recruit up to 40 patients across 15 European centers, and the first patient has already enrolled at the Steno Diabetes Center in Copenhagen. Originally published on 30/05/2017 Imcyse will run its first clinical trial testing a specific immunotherapy that could fin ...

Related Articles